0001071739-22-000232.txt : 20220601 0001071739-22-000232.hdr.sgml : 20220601 20220601183236 ACCESSION NUMBER: 0001071739-22-000232 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220527 FILED AS OF DATE: 20220601 DATE AS OF CHANGE: 20220601 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BROOKS MARK J CENTRAL INDEX KEY: 0001669691 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31826 FILM NUMBER: 22988736 MAIL ADDRESS: STREET 1: 7700 FORSYTH BOULEVARD CITY: ST. LOUIS STATE: MO ZIP: 63105 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CENTENE CORP CENTRAL INDEX KEY: 0001071739 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] IRS NUMBER: 041406317 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7700 FORSYTH BLVD. CITY: ST LOUIS STATE: MO ZIP: 63105 BUSINESS PHONE: 3147254477 MAIL ADDRESS: STREET 1: 7700 FORSYTH BLVD. CITY: ST LOUIS STATE: MO ZIP: 63105 4 1 wf-form4_165412274233819.xml FORM 4 X0306 4 2022-05-27 0 0001071739 CENTENE CORP CNC 0001669691 BROOKS MARK J 7700 FORSYTH BOULEVARD ST. LOUIS MO 63105 0 1 0 0 EVP, Chief Information Officer Common Stock 153755 D Phantom Stock 0.0 2022-05-27 4 A 0 19.374 81.89 A 2022-05-27 2022-05-27 Common Stock 19.374 2187.926 D Common Stock Option (right to buy) 81.85 2031-12-15 Common Stock 6724.0 6724 D Ownership includes 73,245 shares of restricted stock subject to vesting requirements. Each share of phantom stock represents the right to receive the fair market value of one share of Centene common stock. The phantom stock was acquired by Mr. Brooks through regularly scheduled payroll contributions to the Company's deferred compensation plan. The phantom stock has no formal expiration date. The phantom stock will be settled in cash or other non-Company securities upon Mr. Brooks' termination with the Company, or on such other date Mr. Brooks may elect. Performance Stock Option granted on December 15, 2021, may become exercisable on or after the third anniversary of the grant date if the closing price of CNC's common stock equals or exceeds $100 per share for 20 consecutive trading days following the grant date. /s/ Christopher A. Koster (executed by attorney-in-fact) 2022-06-01